Toa Pharmaceutical Industry Launches Live Bacteria Mixed Feed "Bioslee® VC"

- Towards a New Standard for Probiotics for Adult Cattle -
Toa Pharmaceutical Industry is pleased to announce the launch of "Bioslee® VC", a mixed feed containing live bacteria, for the livestock market.
"Bioslee® VC" is a probiotic product for livestock that combines three types of beneficial bacteria that coexist and actively proliferate in the intestinal tract, along with active yeast. We developed this product in response to feedback from users who wanted to care for both the rumen and intestines of cattle but found it cumbersome to administer two separate products.

Features of "Bioslee® VC"

1. By providing Bioslee's three live bacteria and Vistacell's active yeast at once, it optimally affects both the rumen and intestines.

2. Compared to adding Bioslee and Vistacell as two separate products, it reduces labor and total costs.

3. By maintaining good stool quality, it is expected to improve the livestock housing environment.

Scheduled Launch Date for "Bioslee® VC" (Manufacturer Shipment Start Date)

Craft bag 10kg: April 1, 2026

Through "Bioslee® VC", Toa Pharmaceutical Industry will continue to contribute to improving productivity and management in the livestock industry.

[Company Profile]

Trade Name: Toa Pharmaceutical Industry Co., Ltd.

Representative: Tomohide Masuda, President and Representative Director

Location: 2-1-11 Sasazuka, Shibuya-ku, Tokyo 151-0073

Established: January 1948

Business Activities: Manufacturing and sales of pharmaceuticals, quasi-drugs, veterinary drugs, feeds, health foods, and foods

Capital: 70 million yen

URL: https://www.toabio.co.jp/